-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
Scope
Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research.
Indexed in Web of Science (ESCI), Scopus and PubMed
Read more
Scope & Mission
Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
The journal welcomes outstanding contributions in any domain of cancer research: from basic laboratory research to clinical investigation, from prevention to treatment, and from imaging studies to novel treatment strategies.
Frontiers in Oncology is a member of the Committee on Publication Ethics.
Short Name: Front. Oncol.
Abbreviation: fonc
Electronic ISSN: 2234-943X
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Submission
Frontiers in Oncology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Oncology welcome submission of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Systematic Review, Technology Report, Book Review, Data Report, Specialty Grand Challenge, Protocols, Clinical Study Protocol and Classification.
When submitting a manuscript to Frontiers in Oncology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology.
Frontiers Editorial Office
EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
-
- All sections
- Cancer Endocrinology
- Cancer Epidemiology and Prevention
- Cancer Genetics
- Cancer Imaging and Diagnosis
- Cancer Immunity and Immunotherapy
- Cancer Molecular Targets and Therapeutics
- Gastrointestinal Cancers
- Genitourinary Oncology
- Head and Neck Cancer
- Hematology Oncology
- Molecular and Cellular Oncology
- Neuro-Oncology and Neurosurgical Oncology
- Pediatric Oncology
- Pharmacology of Anti-Cancer Drugs
- Radiation Oncology
- Surgical Oncology
- Thoracic Oncology
- Women's Cancer
- Editor(s) found
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This journal has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01